SEC Filings
Enovix Targets $8.5 Million In Annual Savings As It Shifts Resources To Korea
The battery maker eliminated approximately 220 positions and is investing $19 million to double South Korean drone battery capacity.
SEC Filings
The battery maker eliminated approximately 220 positions and is investing $19 million to double South Korean drone battery capacity.
SEC Filings
The quarterly loss widened to $193.6 million, with manufacturing, late-stage trials and launch preparations driving higher costs.
SEC Filings
The drugmaker also lifted its 2030 revenue outlook to more than $1 billion, from approximately $750 million.
SEC Filings
The organ-transplant technology company raised its annual sales outlook as liver and heart volumes grew and logistics added revenue.
SEC Filings
Customer contracts reached $20.3 billion, while IREN targets another $6 billion in funding for its planned expansion.
SEC Filings
Lower administrative costs helped the drug developer, which expects initial Duchenne muscular dystrophy trial data in 2027.
SEC Filings
Eton intends to test faster-release formulations in 2027 after preliminary results from a four-week study in healthy volunteers.
SEC Filings
Testing volumes rose 24%, but sales-team shortfalls, seasonal ordering and delayed development projects held growth below management’s expectations.
SEC Filings
Furoscix contributed $22.4 million in quarterly revenue as MannKind expanded its sales teams and launched ReadyFlow.
SEC Filings
Operating profit reached $187.1 million as purchase volume expanded, though overdue installment loans increased.
SEC Filings
The voice AI company is moving toward hosted services and targeting $120 million in annual savings after buying LivePerson.
SEC Filings
Government Solutions drove sales growth as Kratos raised its adjusted EBITDA outlook and projected further expansion in 2027.